Vulnerability · CVE-2026-31071
API endpoints in LalanaChami Pharmacy Management System (commit 5c3d028) lack authentication middleware.
Published May 19, 2026 · catalog updated Jul 24, 2026 · API endpoints in LalanaChami
Check if you run it
No confirmed exploitation is on record for CVE-2026-31071. EPSS is 0.65%. Act only if a listed version of API endpoints in LalanaChami is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (API endpoints in LalanaChami).
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Critical9.1
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.65%
- Remediation
- Not established
- Affected products
- See sources for product scope
API endpoints in LalanaChami Pharmacy Management System (commit 5c3d028) lack authentication middleware. Unauthenticated remote attackers can exploit this to dump all user records (including bcrypt password hashes) via /api/user/getUserData, modify drug inventory, and access private medical prescription data via /api/doctorOder.
No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.
How to fix CVE-2026-31071
Recommended remediation
No required-action text, fix commit, or clear fixed-version range is stored yet.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-31071. EPSS is 0.65%. Act only if a listed version of API endpoints in LalanaChami is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-306: Missing Authentication for Critical Function. EPSS 0.65%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
May 19, 2026 · NIST NVD
Detected
API endpoints in LalanaChami Pharmacy Management System (commit 5c3d028) lack authentication middleware. Unauthenticated remote attackers can exploit this to dump all user records (including bcrypt password hashes) via /api/user/getUserData, modify drug inventory, and access private medical prescription data via /api/doctorOder.
Jul 24, 2026 · NIST NVD
Updated
API endpoints in LalanaChami Pharmacy Management System (commit 5c3d028) lack authentication middleware. Unauthenticated remote attackers can exploit this to dump all user records (including bcrypt password hashes) via /api/user/getUserData, modify drug inventory, and access private medical prescription data via /api/doctorOder.
Sources
- CVE.orgVulnerability recordCVE-2026-31071
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-31071
30-day exploitation probability 0.7%
first.org - NIST NVDVulnerability recordCVE-2026-31071
API endpoints in LalanaChami Pharmacy Management System (commit 5c3d028) lack authentication middleware. Unauthenticated remote attackers can exploit this to dump all user records (including bcrypt password hashes) via /api/user/getUserData, modify drug inventory, and access priv
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.